(Q38330385)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616523%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

review article

1 reference

title

Oxidative Stress in Alzheimer's Disease: Should We Keep Trying Antioxidant Therapies? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616523%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

0 references

Michelli E S Ferreira

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616523%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Sandro Percário

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616523%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Amanda Soares de Vasconcelos

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616523%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Thyago da Costa Vilhena

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616523%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Thiago Leite da Silva

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616523%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Aline da Silva Barbosa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616523%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Antonio Rafael Quadros Gomes

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616523%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Maria Fani Dolabela

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616523%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

24 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616523%20AND%20SRC:MED&resulttype=core&format=json

Cellular and Molecular Neurobiology

28 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616523%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616523%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616523%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

595-614

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616523%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10571-015-0157-y

28 February 2020

exact match

0 references

cites work

Modulatory effects of vitamin E, acetyl-L-carnitine and α-lipoic acid on new potential biomarkers for Alzheimer's disease in rat model.

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Beta-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1beta- and tumor necrosis factor-alpha (TNFalpha)-dependent, and involves a TNFalpha receptor-associated factor- and NFkappaB-inducing kinase-dependent signalin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Methionine regulates copper/hydrogen peroxide oxidation products of Abeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Dimerisation of N-acetyl-L-tyrosine ethyl ester and Abeta peptides via formation of dityrosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Effect of one-year vitamin C- and E-supplementation on cerebrospinal fluid oxidation parameters and clinical course in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Reactive oxygen species: destroyers or messengers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Aging, energy, and oxidative stress in neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Antioxidant neuroprotection in Alzheimer's disease as preventive and therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Vitamin E protects nerve cells from amyloid beta protein toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Hydrogen peroxide mediates amyloid beta protein toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Cytotoxicity of advanced glycation endproducts in human micro- and astroglial cell lines depends on the degree of protein glycation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

A novel perspective on tau in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Ascorbic acid, cognitive function, and Alzheimer's disease: a current review and future direction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Demonstration of Amyloid Deposits and Neurofibrillary Changes in Whole Brain Sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

NFkappaB-dependent control of BACE1 promoter transactivation by Abeta42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer's amyloid beta-peptide 1-42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Induction of neuronal death by microglial AGE-albumin: implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Activated microglial cells synthesize and secrete AGE-albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Release of excess amyloid beta protein from a mutant amyloid beta protein precursor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Antioxidant protection and neurodegenerative disease: the role of amyloid-beta and tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Betaine attenuates Alzheimer-like pathological changes and memory deficits induced by homocysteine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Regional brain activity of free radical defense enzymes in autopsy samples from patients with Alzheimer's disease and from nondemented controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Regulation of serine protease activity by aluminum: implications for Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Oxidative stress in Alzheimer's disease hippocampus: a topographical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Effects of donepezil on neuropsychiatric symptoms in patients with dementia and severe behavioral disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Cu(II) potentiation of Alzheimer Abeta1-40 cytotoxicity and transition on its secondary structure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Zinc-specific autometallographic in vivo selenium methods: tracing of zinc-enriched (ZEN) terminals, ZEN pathways, and pools of zinc ions in a multitude of other ZEN cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Carotenoid radical chemistry and antioxidant/pro-oxidant properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Antioxidant therapies for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Global prevalence of dementia: a Delphi consensus study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

The neurobiology of zinc in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Synaptic release of zinc from brain slices: factors governing release, imaging, and accurate calculation of concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Involvement of free oxygen radicals in beta-amyloidosis: an hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Neuronal zinc exchange with the blood vessel wall promotes cerebral amyloid angiopathy in an animal model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Platelet phospholipase A(2) activity in Alzheimer's disease and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Alzheimer's disease: its proteins and genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Disease modifying therapy for AD?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Secreted forms of beta-amyloid precursor protein protect hippocampal neurons against amyloid beta-peptide-induced oxidative injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Histopathology and APOE genotype of the first Alzheimer disease patient, Auguste D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Amyloid, the presenilins and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Free Radical Theory of Aging: Inhibition of Amyloidosis in Mice by Antioxidants; Possible Mechanism*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

The role of alterations in membrane lipid composition in enabling physiological adaptation of organisms to their physical environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Proteomic method for the quantification of methionine sulfoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Redox-active metals, oxidative stress, and Alzheimer's disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Diabetes and advanced glycoxidation end products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer's type (SDAT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Amyloid-β and tau--a toxic pas de deux in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Evidence of increased oxidative damage in subjects with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

NIK and IKKbeta interdependence in NF-kappaB signalling--flux analysis of regulation through metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Misfolded truncated protein τ induces innate immune response via MAPK pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Atypical pathways of NF-kappaB activation and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Differential effects of "Advanced glycation endproducts" and beta-amyloid peptide on glucose utilization and ATP levels in the neuronal cell line SH-SY5Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Glyco-oxidation in diabetes and related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Level of an advanced glycated end product is genetically determined: a study of normal twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Oxygen radicals and neuropsychiatric illness. Some speculations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Copper, iron and zinc in Alzheimer's disease senile plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

The neuropathology of Alzheimer's disease: a review with pathogenetic, aetiological and therapeutic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Association of vitamin E and C supplement use with cognitive function and dementia in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Alzheimer's disease and total plasma aminothiols

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

A controlled trial of homocysteine lowering and cognitive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

The role of dicarbonyl compounds in non-enzymatic crosslinking: a structure-activity study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

The centennial of Alzheimer's disease and the publication of "Uber eine eigenartige Erkankung der Hirnrinde" by Alöis Alzheimer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Vitamin E and cognitive decline in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

beta-Amyloid peptide decreases membrane fluidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Glycoxidative stress creates a vicious cycle of neurodegeneration in Alzheimer's disease--a target for neuroprotective treatment strategies?

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

21 January 2018

12 December 2020

Coffee and Maillard products activate NF-kappaB in macrophages via H2O2 production

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Peroxynitrite causes calcium efflux from mitochondria which is prevented by Cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Induction of the mitochondrial permeability transition by peroxynitrite

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Glucose, Advanced Glycation End Products, and Diabetes Complications: What Is New and What Works

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Oxidative stress in Alzheimer's disease: why did antioxidant therapy fail?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging systems in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Risk factors for Alzheimer's disease: role of multiple antioxidants, non-steroidal anti-inflammatory and cholinergic agents alone or in combination in prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

New perspectives on Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Chronic dietary alpha-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Vitamin B12-induced reduction of platelet monoamine oxidase activity in patients with dementia and pernicious anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Elevated cortical zinc in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Immunochemical crossreactivity of antibodies specific for "advanced glycation endproducts" with "advanced lipoxidation endproducts".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Identification of sequence variants and analysis of the role of the glycogen synthase kinase 3 beta gene and promoter in late onset Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Secreted form of amyloid beta protein precursor is involved in the growth regulation of fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Toxic advanced glycation end products (TAGE) theory in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

NMDA receptor activation mediates copper homeostasis in hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Role of the Menkes copper-transporting ATPase in NMDA receptor-mediated neuronal toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

The regulation of amyloid beta protein precursor secretion and its modulatory role in cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Growth factors and vitamin E modify neuronal glutamate toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Physiological production of the beta-amyloid protein and the mechanism of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Altered plasma antioxidant status in subjects with Alzheimer's disease and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Aging and antioxidants modulate rat brain levels of homocysteine and dehydroepiandrosterone sulphate (DHEA-S): Implications in the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Alzheimer disease: an imbalance of proteolytic regulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Radical AGEing in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Dietary supplementation with a combination of alpha-lipoic acid, acetyl-L-carnitine, glycerophosphocoline, docosahexaenoic acid, and phosphatidylserine reduces oxidative damage to murine brain and improves cognitive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Nuclear tau, a key player in neuronal DNA protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

TAGE (toxic AGEs) hypothesis in various chronic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Diagnostic utility of serum or cerebrospinal fluid levels of toxic advanced glycation end-products (TAGE) in early detection of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

The gene defects responsible for familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

beta-Amyloid-mediated vasoactivity and vascular endothelial damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

The enzymatic defence against glycation in health, disease and therapeutics: a symposium to examine the concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Role of oxygen radicals in DNA damage and cancer incidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Diabetes and advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

High molecular weight neurofilament proteins are physiological substrates of adduction by the lipid peroxidation product hydroxynonenal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Advanced Glycation End Product Recognition by the Receptor for AGEs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

α-Tocopherol quinone inhibits β-amyloid aggregation and cytotoxicity, disaggregates preformed fibrils and decreases the production of reactive oxygen species, NO and inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Roles of the receptor for advanced glycation endproducts in diabetes-induced vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Oxidative stress in Alzheimer patients in different stages of the disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Iron, brain ageing and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Alzheimer's disease: the two-hit hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Amyloid beta-protein and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Apolipoprotein E genotype and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Molecular determinants of Alzheimer’s disease Aβ peptide neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0157-Y

Metabolism of the "Swedish" amyloid precursor protein variant in Madin-Darby canine kidney cells

21 January 2018

1 reference

12 December 2020

Oxidative stress-induced dysregulation of arteriolar wall shear stress and blood pressure in hyperhomocysteinemia is prevented by chronic vitamin C treatment

1 reference

12 December 2020

Complete analysis of the presenilin 1 gene in early onset Alzheimer's disease.

1 reference

12 December 2020

Increased antioxidant enzyme activity in amyloid beta protein-resistant cells

1 reference

12 December 2020

Cytotoxic effects of autoxidative glycation

1 reference

12 December 2020

High-dose antioxidant supplements and cognitive function in community-dwelling elderly women

1 reference

12 December 2020

Lipoprotein oxidation: mechanistic aspects, methodological approaches and clinical relevance

1 reference

12 December 2020

Regulation of proteolytic processing of the amyloid beta-protein precursor of Alzheimer's disease in transfected cell lines and in brain slices

1 reference

12 December 2020

Diet and oxidative stress: a novel synthesis of epidemiological data on Alzheimer's disease

1 reference

12 December 2020

Below the radar: advanced glycation end products that detour "around the side". Is HbA1c not an accurate enough predictor of long term progression and glycaemic control in diabetes?

1 reference

12 December 2020

Rivastigmine dermal patch solves eating problems in an individual with advanced Alzheimer's disease

1 reference

12 December 2020

Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts.

1 reference

12 December 2020

RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer's disease

1 reference

12 December 2020

Is antioxidant therapy a viable alternative for mild cognitive impairment? Examination of the evidence.

1 reference

12 December 2020

Advanced glycation endproducts cause lipid peroxidation in the human neuronal cell line SH-SY5Y.

1 reference

12 December 2020

Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease.

1 reference

12 December 2020

Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer's disease.

1 reference

12 December 2020

Energy hypometabolism in posterior cingulate cortex of Alzheimer's patients: superficial laminar cytochrome oxidase associated with disease duration.

1 reference

12 December 2020

Genetic determinants of Alzheimer disease

1 reference

12 December 2020

Interplay between the maillard reaction and lipid peroxidation in biochemical systems

1 reference

12 December 2020

Mechanism of amyloid beta protein induced neuronal cell death: current concepts and future perspectives.

1 reference

12 December 2020

Alpha-lipoic acid as a new treatment option for Alzheimer's disease--a 48 months follow-up analysis.

1 reference

12 December 2020

Are advanced glycation end-products associated with amyloidosis in Alzheimer's disease?

1 reference

12 December 2020

Cholinergic markers in Alzheimer disease

1 reference

12 December 2020

The effect of intravenous vitamin E and menadiol sodium diphosphate on vitamin K dependent clotting factors

1 reference

12 December 2020

The generation of superoxide anions in glycation reactions with sugars, osones, and 3-deoxyosones

1 reference

12 December 2020

Advanced glycation endproducts in ageing and Alzheimer's disease

1 reference

12 December 2020

Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer's disease

1 reference

12 December 2020

Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type.

1 reference

12 December 2020

Cholinergic stimulation of AP-1 and NF kappa B transcription factors is differentially sensitive to oxidative stress in SH-SY5Y neuroblastoma: relationship to phosphoinositide hydrolysis.

1 reference

12 December 2020

Treatment of Alzheimer-type dementia with intravenous mecobalamin

1 reference

12 December 2020

Metals and Alzheimer's disease

1 reference

12 December 2020

Intervention against the Maillard reaction in vivo

1 reference

12 December 2020

Increased protein and lipid oxidative damage in mitochondria isolated from lymphocytes from patients with Alzheimer's disease: insights into the role of oxidative stress in Alzheimer's disease and initial investigations into a potential biomarker fo

1 reference

12 December 2020

Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease beta-amyloid

1 reference

12 December 2020

RAGE on the Toll Road?

1 reference

12 December 2020

The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse.

1 reference

12 December 2020

Nordihydroguaiaretic acid protects hippocampal neurons against amyloid beta-peptide toxicity, and attenuates free radical and calcium accumulation

1 reference

12 December 2020

Effect of aldehydes derived from oxidative deamination and oxidative stress on beta-amyloid aggregation; pathological implications to Alzheimer's disease

1 reference

12 December 2020

Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly

1 reference

12 December 2020

beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis.

1 reference

12 December 2020

Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation

1 reference

12 December 2020

Advanced glycation end-products and the progress of diabetic vascular complications.

1 reference

12 December 2020

Alzheimer's disease--synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts

1 reference

12 December 2020

Oxidative stress and Alzheimer disease

1 reference

12 December 2020

10.1007/S10571-015-0157-Y

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616523%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

28 February 2020

1052854513

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616523%20AND%20SRC:MED&resulttype=core&format=json